関連する実験動画
Updated: May 25, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
まとめ
陽子ポンプ阻害剤ランソプラゾールは,制御不良な喘息と明らかなGER症状のない小児の喘息コントロールを改善しませんでした. 薬は喘息の症状や肺機能を改善せず,呼吸器感染症を増加させた.
科学分野:
- 小児肺病学について
- 胃腸内科 胃腸内科
背景:
- 無症状の胃食道逆流 (GER) は,喘息の小児に多く見られ,喘息のコントロールが悪いことにも寄与する可能性があります.
- 陽子ポンプ阻害剤 (PPI) が,GERの症状が表れない小児における喘息のコントロールを改善する効果は,十分に確立されていない.
研究 の 目的:
- ランソプラゾールの効果を評価するために,制御不良な喘息の子供でも,明らかなGER症状のない子供における喘息のコントロールを改善します.
主な方法:
- ランダム化され,仮面化され,プラセボ対照試験 (喘息児における酸性逆流の研究) で,喘息が制御不能で,吸入型コルチコステロイドを服用している306人の子どもが参加した.
- 参加者は,ランソプラゾールまたはプラセボを24週間投与された.
- 喘息コントロールアンケート (ACQ) のスコアが主なアウトカムであり,肺機能と生活の質は二次的なアウトカムでした.
主要な成果:
- ランソプラゾールは,プラセボと比較してACQスコアを有意に改善しなかった (平均差は0.2単位).
- 肺機能,喘息に関連する生活の質,または喘息のコントロールが悪いエピソードにおいて,有意な違いは観察されなかった.
- 胃食道性逆流 (GER) は,食道性pH研究を行ったサブグループの43%に存在しましたが,ランソプラゾールはこのサブグループで利益を示しませんでした.
- ランソプラゾールを投与した子どもは,より多くの呼吸器感染症を報告した (RR,1.3).
結論:
- ランソプラゾールは,喘息の症状や肺機能の改善に効果的ではなく,喘息のコントロールが不十分で,GERの症状が明らかでない子どもでは効果的ではありません.
- この集団におけるランソプラゾールの使用は,呼吸器感染症のリスクの増加と関連していました.
関連する概念動画
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:30Asthma-IV: Nursing Management
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...